Literature DB >> 18193165

Thrombospondins: from structure to therapeutics.

D D Roberts1.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18193165      PMCID： PMC2430146          DOI： 10.1007/s00018-007-7483-2

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN： 1420-682X            Impact factor:   9.261


× No keyword cloud information.
  13 in total

1.  Activation of the myc oncoprotein leads to increased turnover of thrombospondin-1 mRNA.

Authors:  A Janz; C Sevignani; K Kenyon; C V Ngo; A Thomas-Tikhonenko
Journal:  Nucleic Acids Res       Date:  2000-06-01       Impact factor: 16.971

2.  Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats.

Authors:  M L Iruela-Arispe; M Lombardo; H C Krutzsch; J Lawler; D D Roberts
Journal:  Circulation       Date:  1999-09-28       Impact factor: 29.690

3.  Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia.

Authors:  J Lawler; M Sunday; V Thibert; M Duquette; E L George; H Rayburn; R O Hynes
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

4.  Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction.

Authors:  E J Topol; J McCarthy; S Gabriel; D J Moliterno; W J Rogers; L K Newby; M Freedman; J Metivier; R Cannata; C J O'Donnell; K Kottke-Marchant; G Murugesan; E F Plow; O Stenina; G Q Daley
Journal:  Circulation       Date:  2001-11-27       Impact factor: 29.690

5.  Specific inhibition of endothelial cell proliferation by thrombospondin.

Authors:  P Bagavandoss; J W Wilks
Journal:  Biochem Biophys Res Commun       Date:  1990-07-31       Impact factor: 3.575

6.  A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin.

Authors:  D J Good; P J Polverini; F Rastinejad; M M Le Beau; R S Lemons; W A Frazier; N P Bouck
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

7.  Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines.

Authors:  V Zabrenetzky; C C Harris; P S Steeg; D D Roberts
Journal:  Int J Cancer       Date:  1994-10-15       Impact factor: 7.396

Review 8.  Tumor progression: the effects of thrombospondin-1 and -2.

Authors:  Jack Lawler; Michael Detmar
Journal:  Int J Biochem Cell Biol       Date:  2004-06       Impact factor: 5.085

9.  A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma.

Authors:  Svetomir N Markovic; Vera J Suman; Ravi A Rao; James N Ingle; Judith S Kaur; Lori A Erickson; Henry C Pitot; Gary A Croghan; Robert R McWilliams; Jaime Merchan; Lisa A Kottschade; Wendy K Nevala; Cindy B Uhl; Jacob Allred; Edward T Creagan
Journal:  Am J Clin Oncol       Date:  2007-06       Impact factor: 2.339

10.  Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor.

Authors:  G Taraboletti; D Roberts; L A Liotta; R Giavazzi
Journal:  J Cell Biol       Date:  1990-08       Impact factor: 10.539
View more
  9 in total

1.  A Targeted Mass Spectrometry Strategy for Developing Proteomic Biomarkers: A Case Study of Epithelial Ovarian Cancer.

Authors:  Ruth Hüttenhain; Meena Choi; Laura Martin de la Fuente; Kathrin Oehl; Ching-Yun Chang; Anne-Kathrin Zimmermann; Susanne Malander; Håkan Olsson; Silvia Surinova; Timothy Clough; Viola Heinzelmann-Schwarz; Peter J Wild; Daniela M Dinulescu; Emma Niméus; Olga Vitek; Ruedi Aebersold
Journal:  Mol Cell Proteomics       Date:  2019-07-09       Impact factor: 5.911

2.  MicroRNA miR-27b rescues bone marrow-derived angiogenic cell function and accelerates wound healing in type 2 diabetes mellitus.

Authors:  Jie-Mei Wang; Jun Tao; Dan-Dan Chen; Jing-Jing Cai; Kaikobad Irani; Qinde Wang; Hong Yuan; Alex F Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-10-31       Impact factor: 8.311

3.  Transcriptional and Post-Transcriptional Regulation of Thrombospondin-1 Expression: A Computational Model.

Authors:  Chen Zhao; Jeffrey S Isenberg; Aleksander S Popel
Journal:  PLoS Comput Biol       Date:  2017-01-03       Impact factor: 4.475

4.  Role of TSP-1 as prognostic marker in various cancers: a systematic review and meta-analysis.

Authors:  Shengjie Sun; Huiyu Dong; Tao Yan; Junchen Li; Bianjiang Liu; Pengfei Shao; Jie Li; Chao Liang
Journal:  BMC Med Genet       Date:  2020-06-29       Impact factor: 2.103

5.  The Construction and Comprehensive Analysis of ceRNA Networks and Tumor-Infiltrating Immune Cells in Bone Metastatic Melanoma.

Authors:  Runzhi Huang; Zhiwei Zeng; Guangyu Li; Dianwen Song; Penghui Yan; Huabin Yin; Peng Hu; Xiaolong Zhu; Ruizhi Chang; Xu Zhang; Jie Zhang; Tong Meng; Zongqiang Huang
Journal:  Front Genet       Date:  2019-09-25       Impact factor: 4.599

6.  High Level of Staufen1 Expression Confers Longer Recurrence Free Survival to Non-Small Cell Lung Cancer Patients by Promoting THBS1 mRNA Degradation.

Authors:  Florence Bonnet-Magnaval; Leïla Halidou Diallo; Valérie Brunchault; Nathalie Laugero; Florent Morfoisse; Florian David; Emilie Roussel; Manon Nougue; Audrey Zamora; Emmanuelle Marchaud; Florence Tatin; Anne-Catherine Prats; Barbara Garmy-Susini; Luc DesGroseillers; Eric Lacazette
Journal:  Int J Mol Sci       Date:  2021-12-25       Impact factor: 5.923

7.  Overexpressed Thrombospondin 2 Induced Osteogenic Differentiation of Valve Interstitial Cells via Inhibition of Akt/NF-κB Signaling Pathway to Promote Calcific Aortic Valve Disease Development.

Authors:  Cheng Yu; Danna Wu; Chong Zhao; Chaoguang Wu
Journal:  Dis Markers       Date:  2022-09-08       Impact factor: 3.464

8.  Stilbene glycosides are natural product inhibitors of FGF-2-induced angiogenesis.

Authors:  Sajjad Hussain; Mark Slevin; Nessar Ahmed; David West; Muhammad Iqbal Choudhary; Humera Naz; John Gaffney
Journal:  BMC Cell Biol       Date:  2009-04-23       Impact factor: 4.241

9.  Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.

Authors:  Mathieu Rouanne; Julien Adam; Aïcha Goubar; Angélique Robin; Caroline Ohana; Emilie Louvet; Jiemin Cormier; Olaf Mercier; Peter Dorfmüller; Soly Fattal; Vincent Thomas de Montpreville; Thierry Lebret; Philippe Dartevelle; Elie Fadel; Benjamin Besse; Ken André Olaussen; Christian Auclair; Jean-Charles Soria
Journal:  BMC Cancer       Date:  2016-07-15       Impact factor: 4.430
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.